ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2018
Quality of life and complementary and alternative medicine use among women with breast cancer.
Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Dietary and non-dietary complementary and alternative medicine use in Saudi Arabia: the differential role of associated factors.BMC complementary medicine and therapies · 2026Article
- Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review.Pharmaceutical medicine · 2025Review
- Article
- Quality of Life in Breast Cancer Patients in Saudi Arabia: A Systematic Review.Breast cancer (Dove Medical Press) · 2025Review
- Auricular Therapy to Control Pain in Women With Breast Cancer: Protocol for Systematic Review and Meta-Analysis.JMIR research protocols · 2024Article
- Article
- Use of complementary and alternative medicine for reducing fear of cancer recurrence among cancer survivors: Does it work?Asia-Pacific journal of oncology nursing · 2023Article
- The relationship between use of complementary and alternative medicine and health literacy in chronically ill outpatient cases: a cross-sectional study in southeastern Iran.Frontiers in public health · 2023Article
- Evaluation of the Use, Reasons, and Satisfaction with the Complementary Medicine among Patients Living with a Permanent Ostomy.Evidence-based complementary and alternative medicine : eCAM · 2023Article
- Utilization of complementary and alternative medicine (CAM) by women with breast cancer or gynecological cancer.PloS one · 2023Article
- A triangulated perspective for understanding CAM use in Lebanon: a qualitative study.BMC complementary medicine and therapies · 2022Article
- Use of complementary and integrative health in cancer pain management among patients undergoing cancer treatments: a qualitative descriptive study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- CACA Guidelines for Holistic Integrative Management of Breast Cancer.Holistic integrative oncology. · 2022Article
- Psychosomatic Symptoms in Terminally Ill Cancer Patients and Its Relation With Using Complementary and Alternative Medicines: A Cross-Sectional Study in Southeast Iran.Frontiers in psychiatry · 2022Article
- Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.Evidence-based complementary and alternative medicine : eCAM · 2021Review
- Use of non-conventional medicine and lifestyle change among cancer survivors: evidence from the national VICAN survey.Journal of cancer survivorship : research and practice · 2020Article
- Psychosocial Aspects of Female Breast Cancer in the Middle East and North Africa.International journal of environmental research and public health · 2020Article
- Factors Associated with Health-Related Quality of Life in Women with Breast Cancer in the Middle East: A Systematic Review.Cancers · 2020Review
- Utilization of Complementary and Alternative Medicine Among Patients with Cancer: A Cross-Sectional Study.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComplementary and Alternative Medication (CAM) is commonly used among women with breast cancer to improve their quality of life (QoL). However, few studies examine the prevalence of CAM and its' relation to the patients' QoL among women with breast cancer.
methodsA cross-sectional study was conducted among 95 women with breast cancer at a tertiary hospital in Saudi Arabia. The outcome measure of interest was the QoL. The correlation was used to assess the association between CAM use and QoL. Bivariate and multivariate analyses were used to examine the factors that affect the use of CAM. The data was analysed using Statistical Package for the Social Sciences (SPSS) version 24.0.
resultsCAM use was reported by 81.1% of the study participants. The most commonly used CAM therapy was spiritual therapy 70.5%, followed by honey 36.8%, olive oil 24.2% and 23.2% herbal therapy. We found that those who were undergoing cancer treatment had a significantly higher percentage of CAM usage as compared to those not undergoing cancer therapy (72.6% vs. 8.4%,
conclusionsCAM therapy was commonly used among women in our study sample which was correlated with higher overall global QoL. As CAM is widely used, health care providers may need to discuss the use of CAM with breast cancer women and be up to date on the benefits and risk of CAM use through well-equipped training programs and workshops.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.